NORTH STAR ASSET MANAGEMENT INC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1056559
NEENAH, WI
Position in ALNY
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$364,949
-$74,454 QoQ
Shares Held
1,103
-0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORTH STAR ASSET MANAGEMENT INC holds $9,303,998 across 8 Biotechnology names. ALNY ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,859 | $3,062,817 | |
| 2 | EXEL |
Exelixis, Inc.
|
57,550 | $2,468,319 | |
| 3 | INCY |
Incyte Corp
|
14,408 | $1,356,080 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
16,610 | $1,247,244 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
737 | $569,435 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
1,103 | $364,949 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
4,525 | $215,254 | |
| 8 | ATNM |
Actinium Pharmaceuticals, Inc.
|
20,000 | $19,900 |
All Filings in ALNY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $364,949 | 1,103 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $439,403 | 1,105 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $595,080 | 1,305 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $425,547 | 1,305 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $352,376 | 1,305 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $308,256 | 1,310 | Shares | Sole | 2025-02-19 | |
| 2024-09-30 | $360,289 | 1,310 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $318,330 | 1,310 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $225,669 | 1,510 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $289,986 | 1,515 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $268,306 | 1,515 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $287,759 | 1,515 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $308,492 | 1,540 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $365,981 | 1,540 | Shares | Sole | 2023-03-06 | |
| 2022-09-30 | $308,246 | 1,540 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $297,534 | 2,040 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $329,845 | 2,020 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $342,551 | 2,020 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $381,396 | 2,020 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $339,040 | 2,000 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $282,380 | 2,000 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $259,940 | 2,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $291,200 | 2,000 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $296,220 | 2,000 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $326,550 | 3,000 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||